期刊
EUROPEAN JOURNAL OF OPHTHALMOLOGY
卷 31, 期 6, 页码 3099-3109出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1120672120977359
关键词
Immunosuppressants; ocular therapy; ocular trauma; oral prednisone; sympathetic ophthalmia
资金
- National Natural Science Foundation of China [81671642, 81870651]
This study evaluated factors related to sympathetic ophthalmia in 16 patients and 87 previously reported cases, highlighting ocular therapies as a prevalent risk factor and emphasizing the relatively good visual prognosis with appropriate medical management.
Purpose: To evaluate the factors related to sympathetic ophthalmia (SO) in a series of patients in our ophthalmology center and previously published cases. Methods: A retrospective and noncomparative review was performed on 16 patients with SO attending our ophthalmology center from 2013 to 2019. A total of 87 previously published cases of SO were identified by searching the Medline database from 2009 to 2019. Results: Sixteen patients were included in the analysis, and six cases were induced by transscleral cyclophotocoagulation (TCP). All patients had achieved controlled inflammation at their last follow-up visit. Thirteen patients (81.3%) had improved best-corrected visual acuity (BCVA). A review of the literature revealed 87 previously reported cases of SO. Shared clinical features and treatment outcomes were summarized. Conclusion: Ocular therapies, including both penetrating ocular therapy and non-penetrating ocular intervention, have become increasingly prevalent risk factors for SO, and the latent period has increased compared to past reports. Visual prognosis with appropriate medical management is relatively good.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据